Senores Pharmaceuticals Reappoints Swapnil Jatinbhai Shah as Managing Director with Over 99% Votes in Favor
The company secured shareholder approval through postal ballot concluded November 17, 2026, reaffirming leadership continuity
Senores Pharmaceuticals Limited announced the reappointment of Mr. Swapnil Jatinbhai Shah as Managing Director following a postal ballot completed on November 17, 2026. The special resolution was passed with over 99% votes in favor, reflecting strong shareholder support across promoters and public investors.
Senores Pharmaceuticals Limited
Change in Management
Senores Pharmaceuticals Limited announced the successful reappointment of Mr. Swapnil Jatinbhai Shah as Managing Director, approved by shareholders through a postal ballot ending November 17, 2026. The special resolution received overwhelming support from all voting categories.
The postal ballot voting process started on October 19, 2026 and concluded on November 17, 2026, enabling shareholders to vote remotely on the resolution to reappoint Mr. Shah as Managing Director.
According to the scrutinizer report by Mukesh H. Shah & Co., the resolution received 99.42% votes in favor out of total shares polled, reflecting strong consensus.
Among promoters and promoter group, 82.58% of shares voted, with 100% favoring the reappointment.
Public institutions voted with 49.15% participation, yielding 96.76% votes in favor, while public non-institutions recorded 1.68% voter turnout with 99.996% supporting the resolution.
There were no invalid votes reported, and the resolution was declared passed with the requisite majority as per regulatory requirements.
Highlights
- Postal ballot voting held from October 19 to November 17, 2026.
- Total shares polled were 21,576,368 out of 46,053,588 shares.
- Special resolution to reappoint Managing Director passed with 99.42% votes in favor.
- Promoters and promoter group contributed 82.58% votes polled with 100% favorable votes.
- Public institutions and non-institutions also supported, with 96.76% and 99.996% votes in favor respectively.
- Scrutinizer Mukesh H. Shah & Co. certified the voting results on November 17, 2026.
Key Data Snapshot
What happened
- Senores Pharmaceuticals Limited conducted a postal ballot from October 19 to November 17, 2026.
- Shareholders voted on a special resolution to reappoint Mr. Swapnil Jatinbhai Shah as Managing Director.
- The resolution was passed with over 99% majority as per the scrutinizer's report.
Key details
- Total shares outstanding were 46,053,588 with 46.85% votes cast in the postal ballot.
- Promoter and promoter group votes polled were 17,424,326 with 100% in favor.
- Public institutions showed 49.15% voting participation, voting 96.76% in favor.
- Public non-institutions participated at 1.68%, supporting the resolution by 99.996%.
- No invalid votes were reported by the scrutinizer.
Regulatory and governance context
- The voting process complied with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- Scrutinizer appointed under Companies Act, 2013 and accompanying rules to ensure fair and transparent voting.
- The postal ballot provided remote e-voting in accordance with statutory provisions.
Highlights
- Postal ballot voting held from October 19 to November 17, 2026.
- Total shares polled were 21,576,368 out of 46,053,588 shares.
- Special resolution to reappoint Managing Director passed with 99.42% votes in favor.
- Promoters and promoter group contributed 82.58% votes polled with 100% favorable votes.
- Public institutions and non-institutions also supported, with 96.76% and 99.996% votes in favor respectively.
- Scrutinizer Mukesh H. Shah & Co. certified the voting results on November 17, 2026.
Disclosures
- Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Section 108 of the Companies Act, 2013
- Rule 20 of the Companies (Management and Administration) Rules, 2014
No promoter/promoter group interest in the resolution
More News on Change in Management
View allLatest corporate announcements and market updates in Change in Management.
ICICI Life Insurance's Registrar KFin Technologies Relocates Corporate Office to Kokapet from December 1, 2026
ICICI Life Insurance Limited informed that KFin Technologies Limited, its Registrar and Share Transfer Agent, will move its corporate office to a new location in Kokapet, Telangana, effective from December 1, 2026.
Read Full StoryBritannia Industries Vice President – Sales Rahul Mahajan to Leave Company by November 30, 2026
Britannia Industries Limited has announced that its Vice President - Sales, Mr. Rahul Mahajan, has resigned and will be relieved from his duties effective November 30, 2026.
Read Full StoryLG Electronics India to Lose Two Senior Executives by Year-End Due to Relocation
LG Electronics India Limited confirmed on November 19, 2026, that two key senior management personnel will cease their roles as of December 31, 2026, due to relocation to Korea.
Read Full Story